CN205108044U - Amnion tear way drainage tube of treatment illness in eye - Google Patents
Amnion tear way drainage tube of treatment illness in eye Download PDFInfo
- Publication number
- CN205108044U CN205108044U CN201320718618.2U CN201320718618U CN205108044U CN 205108044 U CN205108044 U CN 205108044U CN 201320718618 U CN201320718618 U CN 201320718618U CN 205108044 U CN205108044 U CN 205108044U
- Authority
- CN
- China
- Prior art keywords
- tear
- amnion
- drainage body
- house steward
- drainage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Prostheses (AREA)
Abstract
The utility model discloses an amnion tear way drainage tube of treatment illness in eye, a serial communication port, including drainage body and pull wire, placenta amnion when the drainage body adopts the women to produce is coiled and is formed, the both ends of pull wire are being binded extend behind the both ends of drainage body. The utility model discloses an intraductal back in tear house steward and the nose is put into in the preparation of placenta amnion when the drainage body directly adopts the women to produce, can be need not to implement the operation of taking out tear way drainage tube by people's bulk absorption, has lightened patient's misery. The daughter cell is planted, tear house steward and the growth of nose inner tube pipe wall epithelial cells after it promotes to dredge to the ideal that mesenchymal stem cells be cell transplantation and organizational project between the amnion in addition to the tear way pipe wall that reaches after the mediation does not form the scar and blocks again, thereby has improved the cure rate. Moreover adopt the pull wire to put into tear house steward and nose inner tube with the drainage body, and operation technique gets up portably, and the risk is little.
Description
Technical field
This utility model relates to a kind of body implant for the treatment of oculopathy, particularly a kind of amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy.
Background technology
Chronic dacryocystitis and obstruction of naso lacrimal duct are clinical ophthalmology commonly encountered diseases, the outer otch route of the nose of operative treatment many employings in the past, have painful large, face leaves over the shortcomings such as cicatrix, therefore, patient is reluctant to accept this Therapeutic Method mostly, in existing treatment technology, adopt nasolacrimal duct send lead-in wire silica gel tube implant method treatment chronic dacryocystitis and obstruction of naso lacrimal duct commonplace, adopt in this way, lacrimal passage can be made flexible smooth, and implant surgery method is simple, silica gel tube softness is flexible, and tissue intersolubility is good.Method one more multiplex in practice adopts single capillary structure, and pipe easily goes out landing outward from upper and lower puncta, and to tear house steward and intranasal pipe weak effect; Two is that silica gel tube of the prior art adopts ball head structure, because upper end is thick, pipe to insert resistance large, easy damaged tissue, puts pipe easily failure for the patient that lachrymal sac is little, easily comes off after putting pipe, the silica gel tube of this structure, be generally only applicable to treat nasolacrimal duct.In addition due to silica gel can not absorb by human body, must implement place a period of time in lacrimal passage after and take out the operation of lacrimal passage drainage tubes.
Utility model content
Technical problem to be solved in the utility model is for the many weak points existing for existing lacrimal passage drainage tubes, and provides a kind of amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy.
Technical problem to be solved in the utility model can be achieved through the following technical solutions:
Treat an amniotic membrane lacrimal passage drainage tubes for oculopathy, it is characterized in that, comprise drain body and draught line, placenta amnion winding when described drain body adopts women to produce forms, and the two ends of described draught line are extended behind the two ends of the described drain body of binding.
In a preferred embodiment of the present utility model, the internal diameter of described drain body is 0.8mm-20mm.
In a preferred embodiment of the present utility model, described draught line is 10-0 surgical thread.
In a preferred embodiment of the present utility model, the length of described drain body is 8-10mm.
Owing to have employed technique scheme, placenta amnion when drain body of the present utility model directly adopts women to produce makes, and inserts after in tear house steward and intranasal pipe, can be absorbed by the body, without the need to implementing the operation of taking out lacrimal passage drainage tubes, alleviate the misery of patient.Amniotic membrane stroma stem cell is the desirable seed cell of cell transplantation and organizational project in addition, it promotes the tear house steward after dredging and intranasal tube wall epithelial cell growth, thus reach the lacrimal passage tube wall after dredging and do not form cicatrix and again block, thus improve cure rate.Moreover adopting draught line that drain body is inserted tear house steward and intranasal pipe, operation technique gets up easy, and risk is little.
Accompanying drawing explanation
Fig. 1 is structural representation of the present utility model.
Detailed description of the invention
See a kind of amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy provided in Fig. 1, figure, comprise drain body 1 and draught line 2, placenta amnion winding when drain body adopts women to produce forms, and internal diameter is 0.8mm-20mm, and length is 8-10mm.Draught line 2 is 10-0 surgical thread, is preferably No. 2 draught lines, and the two ends of draught line 2 are extended behind the two ends of the described drain body 1 of binding.
In operation process, by line sending pin, nasal cavity is sent in one end of draught line 2, adopt crochet hook to be gone out by nose lacrimal passage, lachrymal sac, lacrimal ductule hook one end of draught line 2, then draught line to pull-up, drain body is inserted in nose lacrimal passage, lachrymal sac, lacrimal ductule, wipes out expose portion.
Claims (4)
1. treat an amniotic membrane lacrimal passage drainage tubes for oculopathy, it is characterized in that, comprise drain body and draught line, placenta amnion winding when described drain body adopts women to produce forms, and the two ends of described draught line are extended behind the two ends of the described drain body of binding.
2. the amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy as claimed in claim 1, it is characterized in that, the internal diameter of described drain body is 0.8mm-20mm.
3. the amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy as claimed in claim 1, it is characterized in that, described draught line is 10-0 surgical thread.
4. the amniotic membrane lacrimal passage drainage tubes for the treatment of oculopathy as claimed in claim 1, it is characterized in that, the length of described drain body is 8-10mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320718618.2U CN205108044U (en) | 2013-11-13 | 2013-11-13 | Amnion tear way drainage tube of treatment illness in eye |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320718618.2U CN205108044U (en) | 2013-11-13 | 2013-11-13 | Amnion tear way drainage tube of treatment illness in eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205108044U true CN205108044U (en) | 2016-03-30 |
Family
ID=55563699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320718618.2U Expired - Fee Related CN205108044U (en) | 2013-11-13 | 2013-11-13 | Amnion tear way drainage tube of treatment illness in eye |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205108044U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114939190A (en) * | 2022-06-14 | 2022-08-26 | 健诺维(成都)生物科技有限公司 | Drainage tube material for treating glaucoma and preparation method thereof |
-
2013
- 2013-11-13 CN CN201320718618.2U patent/CN205108044U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114939190A (en) * | 2022-06-14 | 2022-08-26 | 健诺维(成都)生物科技有限公司 | Drainage tube material for treating glaucoma and preparation method thereof |
| CN114939190B (en) * | 2022-06-14 | 2024-01-12 | 健诺维(成都)生物科技有限公司 | Drainage tube material for glaucoma treatment and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN205460381U (en) | Prostate expands and splits pipe with flexible speculum | |
| CN205108044U (en) | Amnion tear way drainage tube of treatment illness in eye | |
| CN201631477U (en) | Minimally invasive aqueous drainage implant for glaucoma | |
| CN204147317U (en) | Nasal cavity is exempted from filling every vacuum extractor | |
| CN203468802U (en) | Lacrimal passage drainage support | |
| CN202875597U (en) | Lacrimal passage stick placed in lacrimal passage for treatment of eye disease | |
| CN205434661U (en) | Tear way drainage ware | |
| CN204306933U (en) | Lacrimal stent | |
| CN207886312U (en) | A kind of implant for anal fistula filling | |
| CN205459331U (en) | Children's tear way pipe | |
| CN104586565A (en) | Lacrimal pump physiological mechanism imitating lacrimal drainage device | |
| CN208864441U (en) | A kind of cervical dilatation foley's tube | |
| CN205612523U (en) | A operation pincers for thorax closed drainage | |
| CN207979848U (en) | A kind of casing probe of the preset lead of Lacrimal passage tube | |
| CN204073054U (en) | A kind of Novel urethral catheter | |
| CN203524845U (en) | Novel lacrimal duct obstruction dilator for ophthalmology | |
| CN208551970U (en) | Conduit is perfused in fallopian tubal | |
| CN202397573U (en) | Integral-type expansion obstetric forceps | |
| CN201104952Y (en) | Tear path drainage tubes | |
| CN201642416U (en) | Artificial nasolacrimal duct | |
| CN207323777U (en) | A kind of sphenotresia surgical drainage drainage tube | |
| CN201759736U (en) | Lacrimal passage dilation drainage tube | |
| CN202409260U (en) | Full lacrimal passage obstruction dredging therapy tube | |
| CN204744587U (en) | In same direction as inserting formula tear way expansion strip | |
| CN204563260U (en) | Pipe inserted by pipeline guiding nasolacrimal duct |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160330 Termination date: 20191113 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |